Monte Rosa Therapeutics, Inc. (GLUE) Dividend History

Monte Rosa Therapeutics, Inc. develops targeted protein degradation therapies aimed at treating difficult-to-drug diseases. Focused on innovative approaches, the company leverages its proprietary technologies to discover and develop novel therapeutics for unmet medical needs.

321 Harrison Avenue, Boston, MA, 02118
Phone: 617-949-2643
Website: https://www.monterosatx.com

Dividend History

Monte Rosa Therapeutics, Inc. currently does not pay dividends

Company News

Page data last updated 07/23/2025 03:23:36 UTC